Key hire
Company
Kira Biotech
Brisbane, QLD
Funding history
Investors
Every investor coverage indicates participated in a round Kira Biotech raised.
What Kira Biotech bought
Companies Kira Biotech acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
People
| Name | Role | Sources |
|---|---|---|
| Dr Dan Baker | CEO | OneVentures portfolio (Mon 3 Aug 2020), OneVentures portfolio (Mon 28 Oct 2019) |
| Helen Roberts | Chief Operating Officer | OneVentures portfolio (Mon 3 Aug 2020), OneVentures portfolio (Mon 28 Oct 2019) |
| Michael Grissinger | Independent Chair | OneVentures portfolio |
Coverage
Stories naming Kira Biotech. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Series A
$20m
Immunology Company Kira Biotech launches with $20M Series A Funding
Brisbane immunology company Kira Biotech has launched with a $20 million Series A, OneVentures leading alongside IP Group and Queensland government support, to progress its lead antibody KB312 into early human studies.